Clinical Trial: Precision Medicine for Indolent Systemic Mastocytosis (PRISM)

U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07757893) titled 'Precision Medicine for Indolent Systemic Mastocytosis (PRISM)' on Aug. 06.

Brief Summary: This study is being done to better understand how symptoms of Systemic Mastocytosis (SM) relate to biological signals and to better understand how different treatments affect these signals.

Study Start Date: Sept. 09

Study Type: OBSERVATIONAL

Condition: Systemic Mastocytosis

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Mayo Clinic

Information provided by (Responsible Party): Thanai Pongdee, Mayo Clinic

Published by HT Digital Content Services with permission from Health Daily Digest....